loader
Please Wait
Applying Filters...

Athena Athena

X

List of All Manufacturers & Suppliers for 20613 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 BRIMONIDINE TARTRATE (1)

filter

01 ALLERGAN (1)

filter

01 SOLUTION/DROPS;OPHTHALMIC (1)

filter

01 0.2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)

filter

01 USA (1)

URL Supplier Web Content
SOLUTION/DROPS;OPHTHAL...
0.2% **Federal Registe...
ALPHAGAN
USA
20613
1996-09-06
DISCN
Abbvie CB

Biotechgate Digital

Not Confirmed

envelop Contact Supplier

Looking for CTD TGA MCC DOSSIER APPLICATION 20613

Looking for CTD TGA MCC DOSSIER APPLICATION 20613 1

19

Allergan Aesthetics, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is BRIMONIDINE TARTRATE, with a corresponding application number 20613 and regulatory information .

proudly manufactured in the

approval since 1996-09-06

Allergan Aesthetics's ALPHAGAN SOLUTION/DROPS;OPHTHALMIC, medication with 0.2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of BRIMONIDINE TARTRATE.

Post Enquiry
POST ENQUIRY